CALL FOR PAPERS

CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

 

 

 

A study of role of intravenous magnesium sulfate in acute exacerbation of copd in a tertiary center

Author: 
Dr. Aishwarya A.P., Dr. Amit Kumar Sharma, Dr. Atal Bihari Meena, Dr. Gunjan Sharma, Dr. Dipanshu Jain, Dr. Varsha Raj Meena, Dr. Ashish Ranjan and Dr. Anil Saxena
Subject Area: 
Health Sciences
Abstract: 

Background: Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) is a common reason for hospitalization and a major cause of death and disability worldwide. Intravenous MgSO4 has shown benefits in acute severe asthma by producing bronchodilation. However, the use of intravenous MgSO4 in acute exacerbations of COPD alone or as an adjuvant to bronchodilators is lacking and more studies are needed to establish its usefulness. Aim/Objectives: To study the role of serum magnesium in acute exacerbation of COPD. To study the role of intravenous magnesium sulfate in acute exacerbation of COPD. Methods: A non-randomized, open-label, parallel-group, placebo-controlled, comparative prospective interventional study, where 100 subjects were allotted into 2 groups (group M and group P) of 50 each to receive either 2g of intravenous MgSO4 or a similar amount of normal saline as placebo along with nebulized salbutamol. The efficacy of MgSO4 was evaluated by measuring PEFR a primary outcome parameter at 0,15,30 and 45 mins. Irrespective of the group serum magnesium of all 100 patients are monitored at the time of admission Statistical Analysis: The statistical software SPSS V.16.0 was used for all analysis of the data &MS Word & Excel have been used to generate graphs, tables, etc. All the results are presented as mean ± SD & the range values for the continuous data. The categorical data are presented as numbers & percentages. A p-value of ≤0.05 was considered statistically significant. Result: The mean difference in the MgSO4 group at every observation was higher than the placebo. The mean change in PEFR (193.04± 43.47) in the MgSO4 group at 45mins observation was Significantly (p=0.0170) higher than in placebo (172.4± 41.47). The serum magnesium level was also monitored but our study was not able to prove a significant correlation between hypomagnesemia and acute exacerbation of COPD. Conclusions: The benefits of intravenous MgSO4 as an adjuvant to bronchodilators in AECOPD resulted in improvement of clinical condition and PEFR. The improvement in PEFR was significantly higher with MgSO4 than with placebo MgSO4 enhances the early bronchodilator response of other drugs and has significant efficacy.

PDF file: 

Announcement

  • FAST PUBLICATION : JULY 2022
  • IMPACT FACTOR: 7.992
  • QUALIS INDEXING
  • HIGH IMPACT FACTOR
  • INTERNATIONAL JOURNAL

IJMCE RECOMMENDATION

ONLINE PAYPAL PAYMENT

CURRENT ISSUE

NEWS

CHIEF EDITOR
Rosane Cavalcante Fragoso, Brasil
ASSOCIATE CHIEF EDITOR

   

Jean-Marc SABATIER
Chief Scientific Officer and Head of a Research Group
France

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

EDITORIAL BOARD

Dr. Abdul Hannan Abdul Mannan Shaikh
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran